Exportar registro bibliográfico


Metrics:

Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease (2018)

  • Authors:
  • USP affiliated authors: FORLENZA, ORESTES VICENTE - FM
  • Unidades: FM
  • DOI: 10.1007/s12035-017-0795-9
  • Subjects: DOENÇA DE ALZHEIMER; BIOMARCADORES; INFLAMAÇÃO; COGNIÇÃO
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Informações sobre o DOI: 10.1007/s12035-017-0795-9 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MAGALHAES, T. N. C.; FORLENZA, O. V. Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Molecular neurobiology, New York, v. 55, n. 7, p. 5689-5697, 2018. Disponível em: < http://dx.doi.org/10.1007/s12035-017-0795-9 > DOI: 10.1007/s12035-017-0795-9.
    • APA

      Magalhaes, T. N. C., & Forlenza, O. V. (2018). Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Molecular neurobiology, 55( 7), 5689-5697. doi:10.1007/s12035-017-0795-9
    • NLM

      Magalhaes TNC, Forlenza OV. Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease [Internet]. Molecular neurobiology. 2018 ; 55( 7): 5689-5697.Available from: http://dx.doi.org/10.1007/s12035-017-0795-9
    • Vancouver

      Magalhaes TNC, Forlenza OV. Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease [Internet]. Molecular neurobiology. 2018 ; 55( 7): 5689-5697.Available from: http://dx.doi.org/10.1007/s12035-017-0795-9

    Referências citadas na obra
    Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204–1222
    Blennow K, Zetterberg H (2009) Cerebrospinal fluid biomarkers for Alzheimer’s disease. J Alzheimers Dis 18(2):413–417
    Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H et al (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382–389
    Agosta F, Pievani M, Geroldi C, Copetti M, Frisoni GB, Filippi M (2012) Resting state fMRI in Alzheimer’s disease: beyond the default mode network. Neurobiol Aging 33(8):1564–1578
    Xia M, Wang Z, Dai Z, Liang X, Song H, Shu N et al (2014) Differentially disrupted functional connectivity in posteromedial cortical subregions in Alzheimer’s disease. J Alzheimers Dis 39(3):527–543
    Balthazar ML, de Campos BM, Franco AR, Damasceno BP, Cendes F (2014) Whole cortical and default mode network mean functional connectivity as potential biomarkers for mild Alzheimer’s disease. Psychiatry Res 221(1):37–42
    Weiler M, Fukuda A, Massabki LH, Lopes TM, Franco AR, Damasceno BP et al (2014) Default mode, executive function, and language functional connectivity networks are compromised in mild Alzheimer’s disease. Curr Alzheimer Res 11(3):274–282
    Liu L, Chan C (2014) The role of inflammasome in Alzheimer’s disease. Ageing Res Rev 15:6–15
    Heneka MT, O'Banion MK (2007) Inflammatory processes in Alzheimer’s disease. J Neuroimmunol 184(1–2):69–91
    Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ (2006) The significance of neuroinflammation in understanding Alzheimer’s disease. J Neural Transm (Vienna) 113(11):1685–1695
    Johnston H, Boutin H, Allan SM (2011) Assessing the contribution of inflammation in models of Alzheimer’s disease. Biochem Soc Trans 39(4):886–890
    Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A et al (2014) Ear2 deletion causes early memory and learning deficits in APP/PS1 mice. J Neurosci 34(26):8845–8854
    Bossu P, Ciaramella A, Salani F, Bizzoni F, Varsi E, Di Iulio F et al (2008) Interleukin-18 produced by peripheral blood cells is increased in Alzheimer’s disease and correlates with cognitive impairment. Brain Behav Immun 22(4):487–492
    Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L (2006) Chitotriosidase and inflammatory mediator levels in Alzheimer’s disease and cerebrovascular dementia. Eur J Neurosci 23(10):2648–2656
    Tarkowski E, Andreasen N, Tarkowski A, Blennow K (2003) Intrathecal inflammation precedes development of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74(9):1200–1205
    Gemma C, Bickford PC (2007) Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction. Rev Neurosci 18(2):137–148
    Bhamra MS, Ashton NJ (2012) Finding a pathological diagnosis for Alzheimer’s disease: are inflammatory molecules the answer? Electrophoresis 33(24):3598–3607
    Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S et al (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73(10):768–774
    Takeda S, Sato N, Morishita R (2014) Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci 6:171
    Banks WA (2010) Blood-brain barrier as a regulatory interface. Forum Nutr 63:102–110
    Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C et al (2012) Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation 9:151
    Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM (2013) Neuroinflammatory phenotype in early Alzheimer’s disease. Neurobiol Aging 34(4):1051–1059
    McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269
    Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43(11):2412–2414
    Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279
    Forlenza OV, Radanovic M, Talib LL, Aprahamian I, Diniz BS, Zetterberg H et al (2015) Cerebrospinal fluid biomarkers in Alzheimer’s disease: diagnostic accuracy and prediction of dementia. Alzheimers Dement (Amst) 1(4):455–463
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
    Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH (2003) Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 61(3b):777–781
    Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149(2):351–356
    Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE et al (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37(9):2220–2241
    de Campos BM, Coan AC, Lin Yasuda C, Casseb RF, Cendes F (2016) Large-scale brain networks are distinctly affected in right and left mesial temporal lobe epilepsy. Hum Brain Mapp 37(9):3137–3152
    Weiler M, Teixeira CV, Nogueira MH, Campos BM, Damasceno BP, Cendes F et al (2014) Differences and the relationship in DMN intrinsic activity and functional connectivity in mild AD and aMCI. Brain Connect 4(8):567–574
    Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33(3):341–355
    Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S et al (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68(11):828–836
    Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F et al (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128(1):92–105
    Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T et al (2008) Inflammaging as a prodrome to Alzheimer’s disease. J Neuroinflammation 5:51
    Alcolea D, Martinez-Lage P, Sanchez-Juan P, Olazaran J, Antunez C, Izagirre A et al (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85(7):626–633
    Bozluolcay M, Andican G, Firtina S, Erkol G, Konukoglu D (2016) Inflammatory hypothesis as a link between Alzheimer’s disease and diabetes mellitus. Geriatr Gerontol Int 16(10):1161–1166
    Stoll G, Jander S, Schroeter M (2000) Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59:81–89
    Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A et al (2006) Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia. J Neurol Sci 249(2):110–114
    Zheng H, Ban Y, Wei F, Ma X (2016) Regulation of interleukin-12 production in antigen-presenting cells. Adv Exp Med Biol 941:117–138
    Town T, Vendrame M, Patel A, Poetter D, DelleDonne A, Mori T et al (2002) Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer’s beta-amyloid(1–42). J Neuroimmunol 132(1–2):49–59
    Azizi G, Mirshafiey A (2012) The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis. Immunopharmacol Immunotoxicol 34(6):881–895
    Das S, Basu A (2008) Inflammation: a new candidate in modulating adult neurogenesis. J Neurosci Res 86(6):1199–1208
    Ma X, Yan W, Zheng H, Du Q, Zhang L, Ban Y, et al (2015) Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res;4. pii: F1000 Faculty Rev-1465. https://doi.org/10.12688/f1000research.7010.1
    Meyaard L, Hovenkamp E, Otto SA, Miedema F (1996) IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 156(8):2776–2782
    Portielje JE, Lamers CH, Kruit WH, Sparreboom A, Bolhuis RL, Stoter G et al (2003) Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Clin Cancer Res 9(1):76–83
    Takeuchi E, Yanagawa H, Suzuki Y, Shinkawa K, Ohmoto Y, Bando H et al (2002) IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions. Lung Cancer 35(2):171–177
    Cunningham C, Hennessy E (2015) Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers Res Ther 7(1):33
    Marottoli FM, Katsumata Y, Koster KP, Thomas R, Fardo DW, Tai LM (2017) Peripheral inflammation, apolipoprotein E4, and amyloid-beta interact to induce cognitive and cerebrovascular dysfunction. ASN Neuro 9(4):1759091417719201
    Labrenz F, Wrede K, Forsting M, Engler H, Schedlowski M, Elsenbruch S et al (2016) Alterations in functional connectivity of resting state networks during experimental endotoxemia—an exploratory study in healthy men. Brain Behav Immun 54:17–26
    Marsland AL, Kuan DC, Sheu LK, Krajina K, Kraynak TE, Manuck SB et al (2017) Systemic inflammation and resting state connectivity of the default mode network. Brain Behav Immun 62:162–170
    Dev SI, Moore RC, Soontornniyomkij B, Achim CL, Jeste DV, Eyler LT (2017) Peripheral inflammation related to lower fMRI activation during a working memory task and resting functional connectivity among older adults: a preliminary study. Int J Geriatr Psychiatry 32(3):341–349
    Critchley HD, Harrison NA (2013) Visceral influences on brain and behavior. Neuron 77(4):624–638
    Gianaros PJ, Wager TD (2015) Brain-body pathways linking psychological stress and physical health. Curr Dir Psychol Sci 24(4):313–321
    McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol (Noisy-le-grand) 47(4):619–635
    Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease—a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2(1):a006346
    Rogers J, Lue LF (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer’s disease. Neurochem Int 39(5–6):333–340
    Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B (1999) TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J 13(1):63–68
    Paouri E, Tzara O, Kartalou GI, Zenelak S, Georgopoulos S (2017) Peripheral tumor necrosis factor-alpha (TNF-alpha) modulates amyloid pathology by regulating blood-derived immune cells and glial response in the brain of AD/TNF transgenic mice. J Neurosci 37(20):5155–5171
    Hennessy E, Gormley S, Lopez-Rodriguez AB, Murray C, Cunningham C (2017) Systemic TNF-alpha produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration. Brain Behav Immun 59:233–244
    Ching S, He L, Lai W, Quan N (2005) IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 19(2):127–137
    Hennessy E, Griffin EW, Cunningham C (2015) Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1beta and TNF-alpha. J Neurosci 35(22):8411–8422
    Emerich DF, Dean RL 3rd, Bartus RT (2002) The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp Neurol 173(1):168–181
    Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview. Mol Neurobiol 50(2):534–544
    Dugue B, Leppanen E, Grasbeck R (1996) Preanalytical factors and the measurement of cytokines in human subjects. Int J Clin Lab Res 26(2):99–105
    Wadhwa M, Thorpe R (1998) Cytokine immunoassays: recommendations for standardisation, calibration and validation. J Immunol Methods 219(1–2):1–5
    Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S et al (2016) Alzheimer’s disease. Lancet 388(10043):505–517
    Popp J, Oikonomidi A, Tautvydaite D, Dayon L, Bacher M, Migliavacca E et al (2017) Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults. Brain Behav Immun 62:203–211
    Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer’s disease. Biol Psychiatry 68(10):930–941

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020